Welcome to our dedicated page for Donaldson news (Ticker: DCI), a resource for investors and traders seeking the latest updates and insights on Donaldson stock.
Donaldson Company, Inc. (NYSE: DCI) is a global manufacturer of technology-led filtration products and solutions, with operations organized into Mobile Solutions, Industrial Solutions and Life Sciences segments. This news page aggregates coverage related to Donaldson’s business performance, corporate actions and participation in key industrial and life sciences events.
Investors and industry followers can use this page to review earnings announcements, such as Donaldson’s reports of record quarterly and full-year sales and earnings, and updates on segment performance across Mobile, Industrial and Life Sciences. Company releases discuss factors like pricing, volume, foreign currency translation, tariff impacts, cost optimization initiatives and guidance for sales, operating margin and earnings.
News items also include capital allocation and dividend updates. Donaldson reports on quarterly cash dividend declarations and notes its membership in the S&P High-Yield Dividend Aristocrats Index, with a long record of consecutive annual dividend increases and quarterly dividend payments. Disclosures on share repurchases and cash flow provide additional context on how the company returns capital to shareholders while funding investments in its operations.
Corporate governance and investor relations activities are another focus of Donaldson’s news. Releases cover the annual meeting of stockholders, director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm. The company also announces participation in investor conferences and webcasts of its earnings conference calls, giving insight into how management communicates with the market.
In addition, Donaldson-related news can highlight developments in its Life Sciences segment, including the role of Isolere Bio by Donaldson in biopharmaceutical purification technologies and collaborations where Isolere Bio participates as a partner. Readers who follow DCI news can track how the company positions its filtration technologies across mobile, industrial and life sciences markets over time.
Purilogics, a Donaldson Life Sciences (NYSE:DCI) business, has launched its first manufacturing-grade product, Purexa™ NAEX Prep membrane technology, designed for biopharmaceutical purification processes. The product, specifically created for purifying supercoiled plasmid DNA, offers high binding capacity, fast cycle times, and an efficient, scalable format.
Manufacturing takes place in an ISO 9001, Class 7 cleanroom certified facility in Bloomington, Minnesota, while R&D occurs in Greenville, South Carolina. The company plans to release additional research-grade and manufacturing-grade products within the Purexa membrane chromatography portfolio throughout 2025 and 2026.
Donaldson Company (NYSE: DCI) has declared a quarterly cash dividend of 30.0 cents per share, payable on August 27, 2025, to shareholders of record as of August 12, 2025.
The company, a global leader in filtration products and solutions, maintains its position in the S&P High-Yield Dividend Aristocrats Index, having increased its dividend for 29 consecutive years. Notably, Donaldson has maintained its quarterly dividend payments for 69 years, demonstrating a strong commitment to shareholder returns.
Donaldson Company (NYSE:DCI) has formed a strategic partnership with Mighty Distributing System of America to expand its heavy-duty filtration solutions distribution. The collaboration combines Donaldson's OE-grade filtration expertise with Mighty's inventory management services, targeting HD fleet facilities, diesel repair centers, and off-highway operations.
The partnership aims to serve a market of over 15 million Class 7 and 8 trucks in the U.S., with the heavy-duty parts aftermarket projected to reach $92.7 billion in 2025. Mighty will provide localized inventory support and premium Donaldson filtration products, including air, oil, fuel, and hydraulic filters, helping facilities reduce surplus stock and improve equipment uptime.
Donaldson Company (NYSE:DCI) celebrated its 2024 patent recipients and Inventor Award winners, recognizing over 100 employees for their contributions to innovation. The company registered 392 new patents in 2024 and currently holds 3,260 active U.S. and international patents. The ceremony honored inventors in five categories: Emerging Innovator, Manufacturing Excellence, Technology Champion, Technology Achievement, and Frank A. Donaldson Award.
Notable winners included Mikayla Yoder for oleophobic materials research, Jon Haag for virtual production line installation, Gert Willems for Clean Seal technology development, Vincent Kayaerts for thermoplastic elastomer seal products, and Dan Tuma for disk drive filtration technology advancements.
Univercells Technologies, a Donaldson Life Sciences business, has launched the scale-X™ nitro controller, expanding its fixed-bed bioreactor portfolio. The new controller operates both 200 and 600 m² scale-X nitro bioreactors, enabling rapid scalability from R&D to commercial production in just 8 months.
The compact system features a 1.6 m² footprint, supports both adherent and suspension cell cultures, and can reduce production costs by 36% to 82% compared to other adherent methods. It's designed for viral vaccines, exosomes, LV and AAV vector production, oncolytic viruses, and recombinant proteins manufacturing. Pre-orders will open in June 2025, with shipments starting in early 2026.
Donaldson Company (NYSE: DCI), a global filtration technology leader, has scheduled its third quarter fiscal 2025 earnings conference call for Tuesday, June 3, 2025, at 9:00 a.m. CT. The live webcast will be accessible through the "Events & Presentations" section of Donaldson's Investor Relations website at IR.Donaldson.com. A replay will be available from approximately 12:00 p.m. CT on the same day.
Founded in 1915, Donaldson operates through three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences, serving diverse industries and advanced markets across six continents with over 140 locations worldwide.